Safety of solanezumab in the expedition-ext study up to 2...

Safety of solanezumab in the expedition-ext study up to 2 years in a mild to moderate Alzheimer’s disease population

Carlson, Christopher D., Sethuraman, Gopalan, Andersen, Scott W., Holdridge, Karen C., Hoog, Sharon L., Hayduk, Roza, Siemers, Eric R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2015.06.1658
Date:
July, 2015
File:
PDF, 44 KB
english, 2015
Conversion to is in progress
Conversion to is failed